CymitQuimica logo

CAS 324759-76-4

:

CCT020312

Description:
CCT020312, identified by its CAS number 324759-76-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. As a small molecule, it is often characterized by its specific structural features, which may include functional groups that contribute to its biological activity. The compound is typically evaluated for its solubility, stability, and reactivity under various conditions, which are crucial for understanding its behavior in biological systems. Additionally, CCT020312 may exhibit specific pharmacokinetic properties, influencing its absorption, distribution, metabolism, and excretion (ADME) in living organisms. Research on this compound may focus on its mechanism of action, efficacy in target diseases, and safety profile, making it a subject of interest in drug development. However, detailed information regarding its precise characteristics, including molecular weight, melting point, and specific biological targets, would require access to specialized databases or scientific literature for comprehensive insights.
Formula:C31H30Br2N4O2
Synonyms:
  • 2(1H)-Quinolinone, 6-bromo-3-[5-(4-bromophenyl)-1-[3-(diethylamino)-1-oxopropyl]-4,5-dihydro-1H-pyrazol-3-yl]-4-phenyl-
  • CCT020312
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
  • CCT020312

    CAS:
    CCT020312
    Purity:≥98%
    Molecular weight:650.4g/mol

    Ref: 54-BUP12542

    5mg
    204.00€
    10mg
    343.00€
    25mg
    570.00€
    50mg
    829.00€
    100mg
    1,152.00€
    500mg
    2,170.00€
  • CCT020312

    CAS:
    <p>CCT020312 is a small-molecule inhibitor that is a selective and potent inhibitor of the P21-activated kinase 4 (PAK4), which is sourced through synthetic organic chemistry. By inhibiting PAK4, this compound disrupts the signaling pathways that are often upregulated in various malignancies, involving proliferation, survival, and cytoskeletal reorganization. Through competitive binding at the ATP-binding site of PAK4, CCT020312 effectively suppresses kinase activity, which is crucial for downstream signaling events associated with oncogenic processes.</p>
    Formula:C31H30Br2N4O2
    Purity:Min. 95%
    Molecular weight:650.4 g/mol

    Ref: 3D-ZMA75976

    25mg
    894.00€
    50mg
    1,173.00€
    100mg
    1,876.00€
  • CCT020312

    CAS:
    <p>CCT020312 (0-9 µM, 24 h) treatment of medium HT29 cells for 24 h resulted in a concentration-dependent loss of P-S608-pRB.Cost-effective and quality-assured.</p>
    Formula:C31H30Br2N4O2
    Purity:98.63%
    Color and Shape:Solid
    Molecular weight:650.4